BIOT Biotech Acquisition Company - Class A

Biotech Acquisition Company is a blank check company. The company was incorporated in 2020 and is based in New York, New York.

On 11/8/2021 the company announced a proposed merger with Blade Therapeutics, Inc. (“Blade”), a biopharmaceutical company based in South San Francisco, Calif.   

$9.97  -0.00 (-0.05%)
As of 05/24/2022 15:59:07 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Financials
Industry:  Shell Companies
Index country:  USA
Country of incorporation:  Sweden
IPO date:  03/18/2021
Outstanding shares:  23,000,000
Average volume:  256,740
Market cap:   $228,965,000
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      B1VN5T8

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%